佰泽医疗2025年度报告

24579334260808687888990140141 20259262025926 15434301–10 108 •202512311,119.8202412315.8%•20251231190.8202412318.4%•202512318.720241231141.7%•2025123117.92024123143.2%•20251231222.32024123131.9%•20251231616.020241231109.4%•202512312024123146.9%2025123136.6% EBITDAEBITDA 02609.HK) 400HIS (MDT) +AI-ready 1,119.81,79443.2%222.331.9%616.0109.4%46.9%36.6% 2,56138%(2025) AI-ready 155 2026331 (i)(ii)(iii) 20251231 202512311,119.820245.8%190.820248.4%8.717.9EBITDA117.8EBITDA144.4 20251231 222.331.9%36.6%10.3 (1)(2)EBITDA(3)EBITDAEBITDA •9.154.448.1%•67•11,0216,45316.9%58.6%20.5% 20251231361 5,4203,93672.6%1.8% 1. (2025) 202510 12HIS 2. •(CACA)DSA+ •AI(2025) •301988DSA •40 • • • 202512312,56136338%21633 1. 400 LIS30%21512 (NPS)1.354.8 2. 134PDCA 24 500 550% AI–ready ESG ESGESGESGESGESGESG ESGESGESG20 1. 1,500400 2. ••300 3. 1015100 2026 2025–2030 1.2.(IoT)3. 155 155 155 •1•5•520262027–20282029–2030 & • 400SOP • AI-readyHISEMRLIS/PACSIOTAIAI Agent+ 20256.16 (i)(ii)(iii) 202512311,119.8202412311,188.85.8%(i)37.4(ii)21.6 (1) (2) (3) 20241231952.03.9%20251231914.6 2024123139.614.1%2025123134.0 20241231190.711.3%20251231169.12025 202412316.666.7%202512312.2202412312025 20241231980.65.3%20251231929.0 202512 31190.8202412 31208.2 20251231132.814.5%20241231144.915.2% 2025123124.170.8%2024123130.376.5% 2025123133.319.7%2024123131.216.4% 202412315.064.0%202512318.2 2024123111.89.3%2025123110.7 20241231165.75.3%20251231157.0 202512 310.5202412 310.6 2025123121.62024123121.7 2025123118.02024123116.9 202512318.7202412313.6 20241231364.04.4%20251231347.9 202412 31202512 31184.9165.2 2024123120251231236.4227.7 2024123120251231643.0643.0 2%20242% 202520241231202520241231 202520241231 2024123162.84.6%2025123159.9 20242025123123 20241231262.19.0%20251231238.62024 20241231120.697.3%20251231237.9 20241231313.928.5%20251231224.3 202412 31115.213.8%2025123199.3 202412312025123130.712.6 20241231160.110.6%20251231143.2 202412312,203.1202512312,556.1202412311,033.020251231935.62024123146.9%2025123136.6% 20241231294.2109.4%20251231616.0 20251231544.520241231517.35.3% 260144.220251231 2024123146.9%2025123136.6% 13.1313.20 20256 13200.0 20263 27188.0 202631214.2214.07(1)8%13.1313.15 2026327 (1)100.0%(2)100.0%(3)EBITDAEBITDA100.0%(4)(5) 20251231 2025123118.9 20251231222.3202431.9% 20251231267.72024258.9% (i)(ii)2024123150.021.8%2025123139.1510 2025123120251231 202512311,998202412312,08020251231318.420241231318.0 (i)(ii)20238 8202569 (i)20251231(ii)(iii)2025123198,130,435 5420237120244242025926 3020004201932019320213 20218 200062007620161201812 5520211292023712025926 3020 200011200580008392005102017820124201780007882015520178 20181 199572000120156 2000 4620211292023712024424 22 200522015122016220177 201712 20037201911 XV63.05% 582023712024424 34201991720005200512009420095201812 20194 1991720046 199712 442023712024424 1915200763022019122021220217 20219 20076201112 6320256 9 30199462007112007122009102009112016102010620166GEM829520171201912019120245201932530.HK2024816 19884200072009101993119979 5420256 9 232003122007920071020157 199362001719944 401993199519982002200220228 198481989719936 39 1520107201262013112016220163201712201712201812 20191201912020320204202232022420251014 201072014120247 54 3020252202472025200221920232202472019620232201792019620173201791995720173 199972003920129 362022320191120223201892019920178201881990820178254464 41202512292025922 16 20082014(MIPA)(IFAC)(FCPA)(CRM)(NSTP) Vistra 20161220229 202112 920256232609 1520251231 2025123115.2%202415.8%11.4%202412.6%2025123130% 2025123140.5%202446.6%14.9%202415.3% 202512315% 2025 11 20256234.22133,105,800 24 2025123124(a) 202512 31555.4 21 20259262025926 202512292025926202592620251229 20259 262025926 20259 262025926 202512 2920251229 13.51(2)(a)(e)(g) 8.10 3.13 89 202512311,998202412312,080 20251231318.420241231318.0 C2 15 20251231XV(a)XV78(b)352(c) (i) (1)L(2)202512311,318,466,823 (ii) 20251231XVXV78352 20251231XV23336 (1)L (2)202512311,318,466,823 (3)Bayway Fund L.P.Rose Violet X LimitedRose Violet XRose Violet XWineberry X LimitedWineberry XWineberry XCrimson X LimitedCrimsonX80%Crimson XBayway Fund L.P.(i) Verdancy CLimitedBest Power SG Capital Pte. Ltd.Marine Green C LimitedMarine Green C Limited90%(ii) Lavender J LimitedUltramarine H Limited90%Bayway Fund L.P.Lavender J Limited10%Amethyst J LimitedAmethyst J LimitedRose Violet XWineberry XCrimson XVerdancy C LimitedBest Power SG Capital Pte. Ltd.Marine Green C LimitedLavender J LimitedUltramarine H LimitedAmethyst J LimitedBayway Fund L.P.Bayway FundL.P. Sugar Berry LimitedSugar Berry33,090,909202512312.51%SugarBerry80%98.33% Cheery Smiley LimitedCheery Smiley13,454,545202512311.02%Cheery Smiley80%97.79% Backspace LimitedBackspace6,500,000202512310.49%Backspace80%80%Sugar BerryCheery SmileyBackspaceSugar BerryCheery SmileyBacksp